Allogene Therapeutics, Inc. (ALLO) Price Prediction & ForecastALLOAllogene Therapeutics, Inc.

Alphio's ALLO stock price prediction model matches the current Allogene Therapeutics, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.25 (-0.40%). The 1-week path is $1.25 (+0.33%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Allogene Therapeutics is not a good buy right now. The current price is $1.31, and the company has reported consistent losses, including a net income loss of $42,677,000 in Q2 2026. Additionally, the RSI is at 27.381, indicating that the stock is oversold, but this does not guarantee a price rebound. The main risk is the ongoing financial strain reflected in a negative forward P/E ratio of 0, suggesting that the company is not expected to generate profits in the near future.

Allogene Therapeutics, Inc. (ALLO) last closed at $1.25, losing -6.02%. These facts feed the 1-day and 1-week ALLO price prediction above.